Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 1.906 USD -1.24% Market Closed
Market Cap: $24.2m

Collplant Biotechnologies Ltd
Investor Relations

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2024
Call Date
Mar 26, 2025
Q4 2024 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Other Earnings Calls

Management

Mr. Yehiel Tal
CEO & Director
No Bio Available
Mr. Eran Rotem CPA
Deputy CEO & CFO
No Bio Available
Mr. Oren Fahimipoor
Vice President of Operations
No Bio Available
Dr. Elana Gazal
Vice President of Research & Development
No Bio Available
Prof. Oded Shoseyov
Founder & Chief Scientist
No Bio Available
Ms. Hadas Dreiher Horowitz
Vice President of Human Resources
No Bio Available

Contacts

Address
Rehovot
4 Oppenheimer Street, P.O. Box 4132
Contacts
+972732325600.0
www.collplant.com